Inicio › Enfermedades de los pulmones › South Carolina
Ensayos clínicos de Enfermedades de los pulmones en South Carolina
11 estudios sobre Enfermedades de los pulmones buscan participantes en South Carolina.
Ciudades en South Carolina
Texto oficial del estudio (inglés)
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Medical University of South Carolina Ashley River Tower, Charleston
- Medical University of South Carolina - SCTR Research Nexus, Charleston
- Medical University of South Carolina, Charleston
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Medical University of South Carolina Infectious Disease Clinic, Charleston
- Medical University of South Carolina Investigational Drug Services (IDS), Charleston
- Medical University of South Carolina Investigational Drug Services Pharmacy, Charleston
- y 3 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07013474American Lung Association (ALA) Lung Health Cohort
- Medical University of South Carolina, Charleston
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 25 a 35 · Todos los sexos · Actualizado el 23 sept 2026 · NCT04543461A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Clinical Research of Rock Hill, Rock Hill
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 22 sept 2026 · NCT06977581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Medical University of South Carolina, Charleston
- Prisma Health Cancer Institute, Greenville
- Lexington Medical Center, West Columbia
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06119581Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Clinical Research of Rock Hill, Rock Hill
ReclutandoFase 3
Edades de 40 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT07284602A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Charleston
ReclutandoFase 2
Edades de 18 a 85 · Todos los sexos · Actualizado el 2 sept 2026 · NCT07333183Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Greenville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 ago 2026 · NCT05624450A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 101, Charleston
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 11 ago 2026 · NCT07555483Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Bogan Sleep Consultants, LLC, Columbia
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 12 nov 2025 · NCT05975983Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- Medical University of South Carolina, Charleston
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2025 · NCT04555161De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.